Sarcoma & GIST
Entrectinib produced responses in patients who had fusions or mutations in target genes.
Missing efficacy data from the pivotal ENLIVEN trial and adverse liver events were points of contention.
ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...
From the Editor
SAN FRANCISCO – A one-two approach to stimulating both innate and adaptive immunity appears to be paying off, suggest early efficacy data from a...
From the Journals
There were no concerning immune-mediated toxicities or changes in HIV-related parameters observed among 73 patients with HIV infection who had...